NDC 0078-1098

SCEMBLIX

Asciminib

SCEMBLIX is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Asciminib Hydrochloride.

Product ID0078-1098_603416c5-f2d1-4d03-a437-71be34553988
NDC0078-1098
Product TypeHuman Prescription Drug
Proprietary NameSCEMBLIX
Generic NameAsciminib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-10-29
Marketing CategoryNDA /
Application NumberNDA215358
Labeler NameNovartis Pharmaceuticals Corporation
Substance NameASCIMINIB HYDROCHLORIDE
Active Ingredient Strength40 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0078-1098-20

60 TABLET, FILM COATED in 1 BOTTLE (0078-1098-20)
Marketing Start Date2021-10-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "SCEMBLIX" or generic name "Asciminib"

NDCBrand NameGeneric Name
0078-1091SCEMBLIXasciminib
0078-1098SCEMBLIXasciminib

Trademark Results [SCEMBLIX]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SCEMBLIX
SCEMBLIX
79281911 not registered Live/Pending
Novartis AG
2020-02-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.